Cargando…

Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study

OBJECTIVES: Outcomes in hepatocellular carcinoma (HCC) are determined by both cancer characteristics and liver disease severity. This study aims to validate the use of inpatient electronic health records to determine liver disease severity from treatment and procedure codes. DESIGN: Retrospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Driver, Robert J, Balachandrakumar, Vinay, Burton, Anya, Shearer, Jessica, Downing, Amy, Cross, Tim, Morris, Eva, Rowe, Ian A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624046/ https://www.ncbi.nlm.nih.gov/pubmed/31292182 http://dx.doi.org/10.1136/bmjopen-2018-028571

Ejemplares similares

Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
por: Ratib, Sonia, et al.
Publicado: (2017)

Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis
por: Cullen, Katherine, et al.
Publicado: (2023)

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Economic burden of cirrhosis in Catalonia: a population-based analysis
por: Miquel, Mireia, et al.
Publicado: (2018)

Psychological experience of inpatients with acute pancreatitis: a qualitative study
por: Ma, Shuli, et al.
Publicado: (2022)

A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2022)

Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
por: Medina Pizaño, Mariana Yazmin, et al.
Publicado: (2023)

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion
por: Weersink, Rianne A, et al.
Publicado: (2016)

Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case–control study
por: Xu, Xiaomei, et al.
Publicado: (2021)

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)
por: Brennan, Paul Noel, et al.
Publicado: (2021)

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
por: Zhou, Zheyu, et al.
Publicado: (2023)

Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
por: Xiao, Shiyu, et al.
Publicado: (2023)

A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis
por: Xing, Yueyi, et al.
Publicado: (2022)

Barriers and facilitators to change in the organisation and delivery of endoscopy services in England and Wales: a focus group study
por: Rapport, Frances, et al.
Publicado: (2012)

Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study
por: Zhang, Jie, et al.
Publicado: (2015)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England
por: Burton, Anya, et al.
Publicado: (2021)

Timing of endoscopic intervention in patients with cirrhosis with acute variceal haemorrhage (TEACH trial): protocol for a randomised clinical trial (RCT)
por: Yang, Zhuoxin, et al.
Publicado: (2022)

A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England
por: Hunt, Natalie, et al.
Publicado: (2022)

Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial
por: Vilar Gomez, Eduardo, et al.
Publicado: (2011)

Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis
por: Xu, Xiaoyong, et al.
Publicado: (2018)

Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case–control study
por: Fu, Kuo-Yu, et al.
Publicado: (2022)

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial
por: Jopson, Laura, et al.
Publicado: (2015)

Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review
por: Härmälä, Suvi, et al.
Publicado: (2019)

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
por: King, A, et al.
Publicado: (2015)

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
por: Harman, David J, et al.
Publicado: (2015)

Nurse-led clinic for patients with liver cirrhosis—effects on health-related quality of life: study protocol of a pragmatic multicentre randomised controlled trial
por: Hjorth, Maria, et al.
Publicado: (2018)

PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
por: Woodhouse, Charlotte Alexandra, et al.
Publicado: (2019)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
por: Mao, Hao-dan, et al.
Publicado: (2023)

Predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis
por: Wang, Peng, et al.
Publicado: (2023)

The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study
por: Rees, James, et al.
Publicado: (2020)

Outcomes of first emergency admissions for alcohol-related liver disease in England over a 10-year period: retrospective observational cohort study using linked electronic databases
por: Bodger, Keith, et al.
Publicado: (2023)

Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study)
por: Heidet, Matthieu, et al.
Publicado: (2018)

Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees
por: Al Bakir, Ibrahim, et al.
Publicado: (2019)

Assessment of a primary care e-support package of automated case finding, simplified treatment algorithm and decision support to increase hepatitis B treatment uptake in primary care clinics in Australia (SIMPLY-B Study): protocol for a pilot evaluation
por: Moussa, Dina, et al.
Publicado: (2023)

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol
por: Arndtz, Katherine, et al.
Publicado: (2017)

Validation of the Kinyarwanda-version Short-Form Leeds Dyspepsia Questionnaire and Short-Form Nepean Dyspepsia Index to assess dyspepsia prevalence and quality-of-life impact in Rwanda
por: Nkurunziza, Arcade, et al.
Publicado: (2016)

Liver blood marker testing in UK primary care: a UK wide cohort study, 2004–2016
por: Scutt, Polly, et al.
Publicado: (2022)

Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults
por: Everitt, Hazel, et al.
Publicado: (2015)

Patients’ accounts of living with and managing inflammatory bowel disease in rural Southern New Zealand: a qualitative study
por: Richard, Lauralie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2us940pgp65bclmb9joa2ltglp